Two years ago, the UK became the first country to approve Casgevy, a Crispr-based therapy for the blood disorders sickle cell disease and β-thalassaemia. This year saw the world’s first personalised Crispr therapy for a baby boy with a…
Crispr gene editing shows promise for HIV cure but faces delivery and reservoir challenges
